{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:16Z","timestamp":1707524536841},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.7759\/cureus.23723","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:16:32Z","timestamp":1648804592000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Case of Domperidone-Induced Acute Dystonia in a Young Adult Due to Consumption of Combination Drug (Proton Pump Inhibitors With Domperidone) and Its Possible Pathomechanism"],"prefix":"10.7759","author":[{"given":"Bob","family":"Daripa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Lucchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12493","article-title":"A history of dystonia: ancient to modern","volume":"4","author":"Newby RE","year":"2017","unstructured":"Newby RE, Thorpe DE, Kempster PA, Alty JE. A history of dystonia: ancient to modern. Mov Disord Clin Pract. 2017, 4:478-85. 10.1002\/mdc3.12493","journal-title":"Mov Disord Clin Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q214","article-title":"Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia","volume":"45","author":"Roy-Desruisseaux J","year":"2011","unstructured":"Roy-Desruisseaux J, Landry J, Bocti C, Tessier D, Hottin P, Trudel JF. Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia. Ann Pharmacother. 2011, 45:e51. 10.1345\/aph.1Q214","journal-title":"Ann Pharmacother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200282","article-title":"Domperidone-induced dystonia: a rare and troublesome complication","volume":"2014","author":"Dhakal OP","year":"2014","unstructured":"Dhakal OP, Dhakal M, Bhandari D. Domperidone-induced dystonia: a rare and troublesome complication. BMJ Case Rep. 2014, 2014:bcr2013200282. 10.1136\/bcr-2013-200282","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-016-2342-6","article-title":"Metoclopramide-induced acute dystonic reaction: a case report","volume":"10","author":"Tianyi FL","year":"2017","unstructured":"Tianyi FL, Agbor VN, Njim T. Metoclopramide-induced acute dystonic reaction: a case report. BMC Res Notes. 2017, 10:32. 10.1186\/s13104-016-2342-6","journal-title":"BMC Res Notes"},{"key":"ref5","article-title":"Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin","volume":"139","author":"Kraft SP","year":"1988","unstructured":"Kraft SP, Lang AE. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. CMAJ. 1988, 139:837-44.","journal-title":"CMAJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1939-4551-1-9-145","article-title":"H1 antihistamines: current status and future directions","volume":"1","author":"Simons FE","year":"2008","unstructured":"Simons FE, Simons KJ. H1 antihistamines: current status and future directions. World Allergy Organ J. 2008, 1:145-55. 10.1186\/1939-4551-1-9-145","journal-title":"World Allergy Organ J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118699","article-title":"P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs","volume":"97","author":"Schinkel AH","year":"1996","unstructured":"Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1996, 97:2517-24. 10.1172\/JCI118699","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14740\/ijcp364","article-title":"Domperidone-related acute dystonia in a young child with underlying abnormal electroencephalogram","volume":"9","author":"Tang KL","year":"2020","unstructured":"Tang KL, Mokhti FA, Fong JY, Anwar HK. Domperidone-related acute dystonia in a young child with underlying abnormal electroencephalogram. Int J Clin Pediatr. 2020, 9:55-8. 10.14740\/ijcp364","journal-title":"Int J Clin Pediatr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0269881120944156","article-title":"Neurobiological mechanisms associated with antipsychotic drug-induced dystonia","volume":"35","author":"Loonen AJ","year":"2021","unstructured":"Loonen AJ, Ivanova SA. Neurobiological mechanisms associated with antipsychotic drug-induced dystonia. J Psychopharmacol. 2021, 35:3-14. 10.1177\/0269881120944156","journal-title":"J Psychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.554","article-title":"Clinical spectrum of drug-induced movement disorders: a study of 97 patients","volume":"10","author":"Chouksey A","year":"2020","unstructured":"Chouksey A, Pandey S. Clinical spectrum of drug-induced movement disorders: a study of 97 patients. Tremor Other Hyperkinet Mov (N Y). 2020, 10:48. 10.5334\/tohm.554","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3587","article-title":"Acute dystonia secondary to domperidone in a pediatric patient","volume":"10","author":"Shahbaz A","year":"2018","unstructured":"Shahbaz A, Elahi K, Affan M, Shahid MF, Sabir A. Acute dystonia secondary to domperidone in a pediatric patient. Cureus. 2018, 10:e3587. 10.7759\/cureus.3587","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101678","article-title":"Dystonia and dopamine: from phenomenology to pathophysiology","volume":"182","author":"Ribot B","year":"2019","unstructured":"Ribot B, Aupy J, Vidailhet M, et al.. Dystonia and dopamine: from phenomenology to pathophysiology. Prog Neurobiol. 2019, 182:101678. 10.1016\/j.pneurobio.2019.101678","journal-title":"Prog Neurobiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2015.02.002","article-title":"Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia","volume":"127-128","author":"Eskow Jaunarajs KL","year":"2015","unstructured":"Eskow Jaunarajs KL, Bonsi P, Chesselet MF, Standaert DG, Pisani A. Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia. Prog Neurobiol. 2015, 127-128:91-107. 10.1016\/j.pneurobio.2015.02.002","journal-title":"Prog Neurobiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320480060028","article-title":"Decongestant-induced blepharospasm and orofacial dystonia","volume":"247","author":"Powers JM","year":"1982","unstructured":"Powers JM. Decongestant-induced blepharospasm and orofacial dystonia. JAMA. 1982, 247:3244-5. 10.1001\/jama.1982.03320480060028","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000001062","article-title":"Acute focal dystonia after a single dose of oral cetirizine in a 9-year-old boy","volume":"35","author":"Sharawat IK","year":"2019","unstructured":"Sharawat IK, Dawman L. Acute focal dystonia after a single dose of oral cetirizine in a 9-year-old boy. Pediatr Emerg Care. 2019, 35:e30-1. 10.1097\/PEC.0000000000001062","journal-title":"Pediatr Emerg Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017675","article-title":"Acute onset of orofacial dystonia from promethazine treatment: a case report","volume":"98","author":"Zhang R","year":"2019","unstructured":"Zhang R, Lai J, Huang J. Acute onset of orofacial dystonia from promethazine treatment: a case report. Medicine (Baltimore). 2019, 98:e17675. 10.1097\/MD.0000000000017675","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2017-0065","article-title":"Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review","volume":"7","author":"Caroff SN","year":"2018","unstructured":"Caroff SN, Aggarwal S, Yonan C. Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review. J Comp Eff Res. 2018, 7:135-48. 10.2217\/cer-2017-0065","journal-title":"J Comp Eff Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/1756285616677004","article-title":"Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study","volume":"10","author":"Miguel R","year":"2017","unstructured":"Miguel R, Mendon\u00e7a MD, Barbosa R, Ladeira F, Lampreia T, Vale J, Bugalho P. Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study. Ther Adv Neurol Disord. 2017, 10:81-90. 10.1177\/1756285616677004","journal-title":"Ther Adv Neurol Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903426171","article-title":"Treatment strategies for dystonia","volume":"11","author":"Cloud LJ","year":"2010","unstructured":"Cloud LJ, Jinnah HA. Treatment strategies for dystonia. Expert Opin Pharmacother. 2010, 11:5-15. 10.1517\/14656560903426171","journal-title":"Expert Opin Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/88435-a-rare-case-of-domperidone-induced-acute-dystonia-in-a-young-adult-due-to-consumption-of-combination-drug-proton-pump-inhibitors-with-domperidone-and-its-possible-pathomechanism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:29Z","timestamp":1707507389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/88435-a-rare-case-of-domperidone-induced-acute-dystonia-in-a-young-adult-due-to-consumption-of-combination-drug-proton-pump-inhibitors-with-domperidone-and-its-possible-pathomechanism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.23723","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}